| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $233K | -98.9% |
| R&D Expense | $74.3M | +55.0% |
| SG&A Expense | $70.3M | -24.1% |
| Operating Income | -$144.8M | -6.6% |
| Pre-tax Income | -$135.2M | +1.0% |
| Income Tax | $6.2M | +256.2% |
| Net Income | -$152.4M | +9.2% |
| EPS (Basic) | -$0.98 | +19.0% |
| EPS (Diluted) | -$0.98 | +19.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.6M | -47.4% |
| Current Assets | $287.1M | -23.4% |
| Total Assets | $305.4M | -26.3% |
| Current Liabilities | $19.9M | -5.0% |
| Long-term Debt | $14.7M | — |
| Total Liabilities | $39.7M | +40.7% |
| Stockholders' Equity | $260.7M | -30.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.5M | -65.2% |
| Capital Expenditures | $773K | +346.8% |
| Investing Cash Flow | -$86.8M | -6.9% |
| Financing Cash Flow | $20.8M | -94.9% |
| Free Cash Flow | -$105.2M | -65.9% |